Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CLINICAL DATA INC NEW Key Ratios

  • Valuation Ratio: CLDA

    P/E (TTM) -1.57
    Price to CashFlow -5.18
    Price to Sales (TTM) 4.99
    Price to Book 50.01
  • Per Share Ratio: CLDA

    Dividend Per Share (TTM) 0.00
    Book Value Per Share -1.44
    EPS Fully Diluted -5.67
    Revenue Per Share 0.48
  • 5 Year Annual Growth: CLDA

    Net Income 99.44%
    Revenue -27.61%
    Dividend Per Share (TTM) -100.00%
    EPS
  • Dividends: CLDA

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.14%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: CLDA

    Operations Margin -648.10%
    Net Profit Margin -1,268.32%
    Gross Profit Margin 37.86%
  • Financial Strength: CLDA

    Quick Ratio (MRQ) 2.13
    Current Ratio (MRQ) 2.05
    LT Debt to Equity (MRQ) 557.44
    Total Debt to Equity (MRQ) 645.08
    Return on Equity (ROE) Per Share -165.34
    Return on Assets (ROA) -76.94
    Return on Invested Capital (ROIC) -133.14
  • Assets: CLDA

    Asset Turnover 0.09
    Inventory Turnover 4.97